Immunological biomarkers predict HIV-1 viral rebound after treatment interruption
Copyright policy )Immunological biomarkers predict HIV-1 viral rebound after treatment interruption
AbstractTreatment of HIV-1 infection with antiretroviral therapy (ART) in the weeks following transmission may induce a state of ‘post-treatment control’ (PTC) in some patients, in whom viraemia remains undetectable when ART is stopped. Explaining PTC could help our understanding of the processes that maintain viral persistence. Here we show that immunological biomarkers can predict time to viral rebound after stopping ART by analysing data from a randomized study of primary HIV-1 infection incorporating a treatment interruption (TI) after 48 weeks of ART (the SPARTAC trial). T-cell exhaustion markers PD-1, Tim-3 and Lag-3 measured prior to ART strongly predict time to the return of viraemia. These data indicate that T-cell exhaustion markers may identify those latently infected cells with a higher proclivity to viral transcription. Our results may open new avenues for understanding the mechanisms underlying PTC, and eventually HIV-1 eradication.
- UNSW Sydney Australia
- University of Cambridge United Kingdom
- Federal University of Rio de Janeiro Brazil
- MRC Clinical Trials Unit United Kingdom
- NIHR Biomedical Research Centre at The Royal Marsden and the ICR United Kingdom
HLA CLASS-I, EXPRESSION, Anti-HIV Agents, 3207 Medical Microbiology, 32 Biomedical and Clinical Sciences, HIV Infections, DETERMINANTS, 613, Article, anzsrc-for: 32 Biomedical and Clinical Sciences, ANTIRETROVIRAL THERAPY, 616, 2.1 Biological and endogenous factors, Humans, anzsrc-for: 3207 Medical Microbiology, POPULATION, anzsrc-for: 3204 Immunology, Science & Technology, MORTALITY, DISEASE PROGRESSION, 3 Good Health and Well Being, Viral Load, INFECTED INDIVIDUALS, CD4 Lymphocyte Count, 3204 Immunology, Multidisciplinary Sciences, Infectious Diseases, Withholding Treatment, T-CELLS, HIV-1, HIV/AIDS, Sexually Transmitted Infections, Science & Technology - Other Topics, Infection, Biomarkers, RESPONSES
HLA CLASS-I, EXPRESSION, Anti-HIV Agents, 3207 Medical Microbiology, 32 Biomedical and Clinical Sciences, HIV Infections, DETERMINANTS, 613, Article, anzsrc-for: 32 Biomedical and Clinical Sciences, ANTIRETROVIRAL THERAPY, 616, 2.1 Biological and endogenous factors, Humans, anzsrc-for: 3207 Medical Microbiology, POPULATION, anzsrc-for: 3204 Immunology, Science & Technology, MORTALITY, DISEASE PROGRESSION, 3 Good Health and Well Being, Viral Load, INFECTED INDIVIDUALS, CD4 Lymphocyte Count, 3204 Immunology, Multidisciplinary Sciences, Infectious Diseases, Withholding Treatment, T-CELLS, HIV-1, HIV/AIDS, Sexually Transmitted Infections, Science & Technology - Other Topics, Infection, Biomarkers, RESPONSES
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).160 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 1% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 1%
Citations provided by BIP!Popularity provided by BIP!